• LAST PRICE
    159.3800
  • TODAY'S CHANGE (%)
    Trending Up2.2900 (1.4578%)
  • Bid / Lots
    159.6500/ 2
  • Ask / Lots
    162.5000/ 1
  • Open / Previous Close
    157.9100 / 157.0900
  • Day Range
    Low 157.5900
    High 159.6700
  • 52 Week Range
    Low 148.5100
    High 179.9200
  • Volume
    8,750,521
    average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Line Graph See accessible table below
News Volume Accessibility Table
DateIndex Fund Price vs. News Density
11/4$164.60
11/5$163.43
11/8$162.87
11/9$162.51
11/10$164.27
11/11$163.06
11/12$165.01
11/15$163.52
11/16$162.67
11/17$163.28
11/18$162.40
11/19$162.89
11/22$159.70
11/23$160.69
11/24$160.24
11/26$159.20
11/29$159.75
11/30$155.93
12/1$158.08
12/2$157.09
12/3$159.38

1 hour ago by Thomson Reuters
Companies Mentioned: JNJ, PFE, MRNA

Dec 4 (Reuters) - The United States had administered 468,516,782 doses of COVID-19 vaccines in the country as of Saturday morning and distributed 581,...

1 hour ago by Thomson Reuters
Companies Mentioned: JNJ, PFE, MRNA

Dec 4 (Reuters) -

* U.S. CDC SAYS DELIVERED 581,107,805 DOSES OF COVID-19 VACCINE AS OF DEC 4 VERSUS 580,893,145 DOSES DELIVERED AS OF DEC 3

* U.S. CDC ...

22 hours ago by PR Newswire
Companies Mentioned: JNJ

The Janssen Pharmaceutical Companies of Johnson & Johnson (NYSE: JNJ) today announced it will present data from six company-sponsored studies in support of their respiratory syncytial virus (RSV) adult vaccine candidate at the Eighth European Scientific Working Group on Influenza (ESWI) meeting. The cornerstone of Janssen's presence at ESWI will be a series of presentations detailing findings from the Phase 2b CYPRESS trial in adults at increased risk for RSV.

3:25PM ET on Friday Dec 03, 2021 by Thomson Reuters
Companies Mentioned: JNJ, PFE, MRNA

Dec 3 (Reuters) - The United States has administered 466,348,132 doses of COVID-19 vaccines in the country as of Friday morning and distributed 580,89...

3:18PM ET on Friday Dec 03, 2021 by Thomson Reuters
Companies Mentioned: JNJ, PFE, MRNA

Dec 3 (Reuters) - U.S. CDC:

* U.S. CDC SAYS DELIVERED 580,893,145 DOSES OF COVID-19 VACCINE AS OF DEC 3 VERSUS 578,263,565 DOSES AS OF DEC 2

* U.S. CDC ...

Peers Headlines

Today

1 hour ago by Thomson Reuters
Companies Mentioned: JNJ, PFE, MRNA

Yesterday

23 hours ago by Thomson Reuters
Companies Mentioned: PFE

4:52PM ET on Friday Dec 03, 2021 by Thomson Reuters
Companies Mentioned: PFE

4:22PM ET on Friday Dec 03, 2021 by Thomson Reuters
Companies Mentioned: ABBV